PureTech-founded Seaport outlines GlyphAgo trial timeline
Seaport said it plans to start a Phase 2/3 trial of GlyphAgo in the first half of 2027 and expects topline data by the end of 2028. It also said topline data from the Phase 2a trial is anticipated in early 2028.